The company was founded in April 1997, completed its initial public offering of shares and listed on September 25, 2007. As the reform of the medical service industry continues to deepen, excellent private hospitals will achieve rapid development, and the profitability of target hospitals will continue to increase steadily in subsequent years. After the transaction is completed, the injection of high-quality assets will greatly enhance the profitability of listed companies, thereby maximizing shareholder value. The company is a listed company whose main business is providing medical services. Corporate honors: It won the third prize for the application of new medical and health technology at the provincial level in 2018, etc.
相关临床试验
51
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
2003
已完成
43
84.3%
终止
1
2.0%
Unknown
7
13.7%
暂无批准数据
